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GLP-2 Suppresses LPS-Induced Inflammation in Macrophages by Inhibiting ERK Phosphorylation and NF-κB Activation
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Peritoneal macrophages cultures and treatments
Peritoneal exudates were obtained from Balb/c female mice by lavage 4 days after an intraperitoneal injection of 4 ml sterile 4% thioglycollate broth. After washing with RPMI 1640 medium, the cell suspensions were centrifuged at 800 g at 4 °C for 5 min. The red blood cells were eliminated by ACK buffer and the cells were washed and resuspended in RPMI 1640 supplemented with 10% inactivated FBS, 10 mM HEPES, 2 mM glutamine, and 100 U/ml penicillin-100 mg/ml streptomycin. Peritoneal macrophages were plated in 6-cm tissue culture dishes at 37 °C in a 5% CO 2 humidified atmosphere. Changes in cell morphology and growth conditions were carefully monitored using an inverted microscope. Macrophages were precultured in serum-free RPMI 1640 medium for 24 h to reduce mitogenic effects. Macrophages were pretreated with various concentrations of GLP-2 for 1 h and stimulated with LPS.
Cell viability assay
Cell viability was determined by MTT assay. Briefly, macrophages were seeded into 96-well plates at a density of 2×10 4 cells per well 24 h before treatment. Cells were treated with various concentrations of GLP-2 for the indicated time periods followed by incubating with 5 mg/ml of MTT working solution for 4 h at 37 °C. After added 100 μl of DMSO to dissolve the crystals, the absorbance of each well at 570 nm was measured using a Synergy 2 Multi-Mode Microplate Reader (BIO-TEK, INC). Three replicates were carried out for each of the different treatments.
RNA extraction, reverse transcriptase PCR and quantitative real-time PCR analysis
Total RNA was extracted from peritoneal macrophages using TRIzol (Invitrogen, Carlsbad, CA, USA) according to the supplier's protocol. Complementary DNA (cDNA) was generated from 5 μg of total RNA using PrimeScript RT reagent Kit with gDNA Eraser (Takara Shuzo Co, Ltd, Kyoto, Japan). The mRNA levels of various genes were evaluated by quantitative polymerase chain reaction (qRT-PCR) analysis and the SYBR Green QuantiTect RT-PCR Kit (Roche, South San Francisco, CA, USA), performed in triplicate for each sample. The relative expression levels of iNOS, COX-2, TNF-α, IL-1β and IL-6 were calculated relative to β-actin using the comparative cycle threshold method. The primer sequences for the tested genes are shown in Table 1 .
ELISA
Macrophages seeded in 24-well plates were pretreated with various concentrations of GLP-2 for 1 h followed by stimulation with LPS (100 ng/ml) for another 12 h. After stimulation, the culture media were collected and centrifuged at 13,000 g for 3 min. The levels of cytokines in the supernatants for TNF-α, IL-1β and IL-6 were determined by ELISA (BioLegend, San Diego, CA, USA) according to the manufacturer's instructions. Three replicates were performed for each of the different treatments.
Western blot analysis
Cells were harvested with ice-cold PBS and centrifuged at 13,000×g for 3 min at 4 °C. Nuclear and cytosolic extracts were prepared using a Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime Institute 
Statistical analyses
The results are expressed as the means ± SD. Data were analyzed using the statistical software package SPSS 12.0(SPSS Inc, Chicago, IL, USA). Groups were compared by one-way analysis of variance (ANOVA) followed by the least significant difference test. A P value of less than 0.05 was considered statistically significant, and values less than 0.01 were considered markedly significant. and 10 -6 M) for 1 h and stimulated with LPS (100 ng/ml) for 4 h to investigate the effect of GLP-2 on the activation of LPS-stimulated macrophages. iNOS and COX-2 were examined by Western blotting and qRT-PCR. GLP-2 notably dose-dependently inhibited the increased expression of iNOS and COX-2 proteins and mRNA stimulated by LPS (Fig. 1 ).
Results

GLP-2 inhibits LPS-stimulated expression of iNOS and COX
GLP-2 attenuates LPS-stimulated the production of the pro-inflammatory cytokines TNF-a, IL-1β and IL-6 at the transcriptional and translational levels in macrophages
Pro-inflammatory cytokines (including TNF-α, IL-1β and IL-6) play important roles in the inflammatory process. Macrophages were stimulated with LPS (100 ng/ml) in the presence or absence of GLP-2 (10 -9
, 10 -8
, 10
-7 and 10 -6 M) to investigate whether GLP-2 represses the production of these pro-inflammatory cytokines. Fig. 2 shows that the significant increases in the proteins and mRNA levels of TNF-α (Figs. 2A, 2B), IL-1β ( Fig. 2E ) and IL-6 (Figs. 2C, 2D) resulting from the LPS stimulation were inhibited by GLP-2 in a dose-dependent manner in macrophages. The secretion of IL-1β was not detected in cell culture supernatants. We investigated the dose effect of GLP-2 on cell viability by the MTT assay to determine the GLP-2 cytotoxicity. Macrophages were incubated with various doses of GLP-2 for 24 h. The MTT assay showed that GLP-2 did not affect cell viability even at a high concentration of 10 -6 M ( Fig. 2F) , which demonstrates that GLP-2 at non-cytotoxic levels suppressed LPSinduced inflammatory responses in macrophages via attenuation of iNOS, COX-2 and proinflammatory cytokines expression in our experiments.
Effects of GLP-2 are not mediated by the GLP-2 receptor
The GLP-2 receptor (GLP-2R) is the functional receptor of GLP-2. We investigated whether GLP-2R mRNA was expressed in macrophages to analyze whether this receptor mediates anti-inflammation of GLP-2. Fig. 3 shows that GLP-2R mRNA was not detected in macrophages. Therefore, GLP-2 can not act on macrophages via the GLP-2 receptor.
GLP-2 inhibits LPS-induced NF-κB translocation, IκB-α degradation and IκB-α phosphorylation
The NF-κB pathway is a key mediator of inflammation, and it is activated via toll-like receptors (TLRs) which increase pro-inflammatory enzymes (iNOS and COX-2) and proinflammatory cytokines (TNF-α, IL-1β and IL-6). The study examined the effect of GLP-2 on NF-κB to further elucidate the mechanisms of GLP-2 on the inhibition of expression of iNOS, COX-2 and pro-inflammatory cytokines in macrophages. Our previous study of LPS stimulation demonstrated that NF-κB translocation, IκB-α degradation and IκB-α phosphorylation reached a maximum at 30 min and then decreased gradually in macrophages. Macrophages were pretreated with various doses of GLP-2 (10 -9
, 10 -8 , 10
-7 and 10 -6 M) for 1 h and stimulated with LPS (100 ng/ml) for 30 min. Nuclear and cytosolic extracts were isolated, and NF-κB p65 subunits in the nuclear and cytosolic fractions were quantified by Western blotting. Fig. 4 shows that LPS sharply increased the translocation of NF-κB p65 from the cytosol to the nucleus, and this increase was inhibited dose-dependently by pretreatment with GLP-2. The LPS-mediated translocation of NF-κB to the nucleus is preceded by the phosphorylation and degradation of IκB-α. Therefore, we also examined protein levels of phosphorylation and degradation of IκB-α by Western blotting analysis. GLP-2 dose-dependently inhibited Xie 
the LPS-induced phosphorylation and degradation of IκB-α (Fig. 4) . These results indicated that GLP-2 suppresses LPS-induced inflammatory responses, at least in part, through the inhibition of LPS-induced NF-κB translocation, IκB-α degradation and IκB-α phosphorylation in macrophages.
GLP-2 suppresses LPS-induced ERK phosphorylation in macrophages
MAPK signaling pathways play an important role in the regulation of inflammatory mediator production. Therefore, we investigated the effects of GLP-2 on the activation of 
, 10
-7 and 10 -6 M) 1 h prior to incubation with LPS (100 ng/mL) for 30 min. NF-κB p65, IκB-α, and p-IκB-α proteins in the cytosol (Cy) and nuclear (N) fraction were determined by Western blotting. Each immunoreactive band was digitized, and the results are expressed as a ratio of β-actin or PCNA levels. The ratio of the normal group band was set to 1.00. Data are expressed as the means ± SD of three independent experiments. # Significant compared to control alone, p<0.05. ** P<0.01, *P<0.05, significantly different compared to the GLP-2-untreated LPS-stimulated group. , 10 -7 and 10 -6 M) for 1 h and stimulated with LPS (100 ng/ml) for 30 min. Cytoplasmic proteins were extracted, and the phosphorylation of p38, ERK1/2 and JNK was examined by Western blotting. The results showed that LPS sharply increased the phosphorylation of ERK, p38-MAPK and JNK, and ERK phosphorylation was inhibited dose-dependently by pretreatment with GLP-2 (Figs. 5A, 5B) . However, the increased phosphorylation of JNK (Figs 5A, 5D) and p38-MAPK (Figs. 5A, 5C ) were not . attenuated by LPS stimulation. The levels of non-phosphorylated MAPK isoforms did not vary remarkably between groups.
Discussion
GLP-2 is an intestinotrophic peptide that is secreted by enteroendocrine L-cells in
response to nutrient ingestion [21] . GLP-2 has several beneficial actions in the gut, including increased mucosal growth, blood flow and digestive and absorptive function [12, 13, 22, 23] . Although recent reports have shown that GLP-2 exerts an anti-inflammatory action [14, , 10
-7 and 10 -6 M) for 1 h and incubated with LPS (100 ng/mL) for 30 min. Cell lysates were prepared and subjected to Western blotting using p-JNK54/46, p-p38, or p-ERK1/2 antibodies. Each immunoreactive band was digitized and the results are expressed as a ratio of β-actin levels. The ratio of the normal group band was set to 1.00. Data are expressed as the means ± SD of three independent experiments.
# Significant compared to control alone, p<0.05. ** P<0.01, *P<0.05, significantly different compared to the GLP-2-untreated LPS-stimulated group. 20, 24, 25] , the underlying molecular mechanisms have not been resolved. Therefore, more detailed mechanisms must be elucidated. This study analyzed the molecular mechanism by which GLP-2 suppresses inflammation following LPS stimulation in macrophages, and we found that GLP-2 significantly inhibited LPS-induced enhancement of pro-inflammatory enzymes (iNOS and COX-2) and pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) expression in macrophages at the mRNA and protein levels, which provides an underlying mechanism for the anti-inflammatory effects of GLP-2 in vitro. First, we examined the effect of GLP-2 on iNOS and COX-2 expression, which are two important inflammatory factors [9] . GLP-2 (10 -9
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, 10
-7 and 10 -6 M) significantly inhibited the protein and mRNA expression of iNOS and COX-2 in a dose-dependent manner in LPS-stimulated macrophages, which suggests a possible beneficial effect of GLP-2 via the attenuation of macrophages activation and the subsequent production of inflammatory mediators. Therefore, GLP-2 would be beneficial for delaying the progression of inflammatory diseases.
Macrophages activation cause the release of pro-inflammatory cytokines, including TNF-α, IL-1β and IL-6 [26] . This pro-inflammatory response by macrophages is protective in fighting off pathogens such as bacteria, in normal circumstances. In contrast, under pathological conditions induced by certain insults, including oxidative stress and excitotoxicity, macrophages can be over-stimulated and produce an excess of pro-inflammatory cytokines, which can lead to pathological conditions, such as septic shock, rheumatoid arthritis, and other chronic inflammatory diseases [27] . This study investigated whether GLP-2 inhibits the LPS-induced production of pro-inflammatory cytokines in macrophages. Our data suggest that GLP-2 significantly reduced LPS-induced protein and mRNA expression levels of TNF-α, IL-1β and IL-6. We detected the mRNA expression of IL-1β, but not protein secretion, which may be relevant to the maturation of IL-1β. In mammals, inflammasomes are composed of sensory NLRs, an adaptor protein called ASC, and the caspase-1 protease, and their activation results in the processing of pro-caspase 1 into activated caspase 1, which cleaves pro-IL-1β into the secreted IL-1β cytokine [28, 29] . The concentration of LPS used in this paper may have been too low to initiate inflammasome assembly, which is essential for the maturation of IL-1β. These results suggest that GLP-2 has the potential to act directly on macrophages to inhibit pro-inflammatory cytokines production.
The GLP-2R is a 7-transmembrane domain GPCR belonging to the glucagons-secretin receptor superfamily that shares sequence homology with glucagon and GLP-1 receptors [30] . GLP-2 has been identified as an endogenous ligand of the receptor [31] . Yusta B et al. failed to detect GLP-2R mRNA transcripts in a variety of intestinal epithelial cell lines, including Caco-2 and T84 cells using RT-PCR analysis [32] . GLP-2 produced a dose-dependent (10 nM to 10 μM) increase in [ 3 H]thymidine incorporation in both of these cell lines [33] [34] [35] . In addition, pertussis toxin inhibits GLP-2-induced proliferation in Caco-2 cells [36] , which suggests the possible existence of an as yet unidentified second GLP-2R for GLP-2 to couple to different G-protein subunits and activate multiple signaling pathways, and this type of non-classical signaling has not been observed with other PGDP peptides [37] . We investigated GLP-2R mRNA expression in macrophages to analyze whether this receptor mediated the anti-inflammation effects of GLP-2. Unexpectedly, GLP-2R mRNA was not detected in macrophages, which suggests that another receptor mediates inhibition of proinflammatory mediators of GLP-2.
NF-κB is clearly one of the most important regulators of pro-inflammatory gene expression. The synthesis of cytokines, such as TNF-α, IL-1β and IL-6, is mediated by NF-κB, as is the expression of COX-2 and iNOS [9] . In resting cells, NF-κB dimers are sequestered in the cytosol by inhibitory proteins of the IκB family [38] . The crucial step in NF-κB activation is the phosphorylation of IκB proteins by the activating IκB kinase complex. Inhibitor of nuclear factor kappa-B kinase 2 (IKK2) is the critical kinase subunit inducing the canonical signaling pathway, which is essentially involved in the regulation of inflammation. The phosphorylation of inhibitory IκB proteins initiates their ubiquitination and subsequent proteasomal degradation, followed by the release and nuclear translocation of active NF-κB dimers, which induces the expression of NF-κB target genes [39] [40] [41] . We examined whether GLP-2-mediated signaling pathways modulate NF-κB signaling to study the molecular mechanisms underlying the anti-inflammatory effect of GLP-2. Incubation of macrophages with LPS caused a marked degradation of cytosolic IκB-α, phosphorylation of IκB-α and NF-κB p65 translocation into the nucleus, but pretreatment with GLP-2 significantly inhibited IκB-α degradation, IκB-α phosphorylation and NF-κB p65 nuclear translocation. These results indicated that GLP-2 suppresses LPS-induced inflammatory responses, at least in part, through the inhibition of LPS-induced IκB-α degradation, IκB-α phosphorylation and NF-κB p65 nuclear translocation in macrophages.
MAPKs are a family of serine/threonine protein kinases responsible for most cellular responses to cytokines and external stress signals, and these kinases are crucial for the regulation of the production of inflammation mediators [42] . We investigated the effect of GLP-2 on the activation (phosphorylation) of three MAPKs induced by LPS in macrophages to further elucidate the mechanisms of GLP-2 on the inhibition of expression of iNOS, COX-2 and pro-inflammatory cytokines in macrophages. The results showed LPS sharply increased the phosphorylation of ERK, p38-MAPK and JNK, and ERK phosphorylation was inhibited dose-dependently by pretreatment with GLP-2. However, the increased phosphorylation of JNK and p38-MAPK after LPS stimulation was not attenuated. Elaine de Heuval et al. have demonstrated that GLP-2 regulated VIP expression via increasing the phosphorylation of ERK1/2 in enteric neurons that naturally express the GLP-2R [43] . T. Angelone proved that GLP-2 increase phosphorylation of ERK1/2 in the rat heart that naturally expresses the GLP-2R [44] . GLP-2 induces proliferation of Caco2 cells that did not express the GLP-2R by increasing phosphorylation of ERK1/2 [45] . However, Yustaet al. showed that GLP-2 inhibited ERK1/2 activity in BHK fibroblasts transfected with the rat GLP-2 receptor [46] . So, the effect of GLP-2 on phosphorylation of ERK1/2 is controversial now. In our study, only treatment with GLP-2 did not affect phosphorylation of ERK1/2. However, GLP-2 can inhibit LPS induced phosphorylation of ERK1/2. The apparent divergence of the actions of the effects of GLP-2 depending on acting through the native receptor or the putative novel signaling pathway. Additional studies will be required to elucidate the intracellular pathways involved in the GLP-2 effects on phosphorylation of ERK1/2. Our results suggested that the GLP-2-mediated attenuation of pro-inflammatory mediators was associated with the downregulation of ERK phosphorylation.
Macrophage polarization is driven by cues in the tissue microenvironment, which can include cytokines, growth factors, and microorganism-associated molecular patterns. At least in vitro, LPS-activated macrophages after a few hours become unable to reactivate a large fraction of pro-inflammatory genes following restimulation [47] . However, they retain the ability to induce the expression of many other genes, including IL-10 [48] , for example. This altered state of responsiveness to secondary stimulation is commonly referred to as endotoxin tolerance and results in a global and sustained switch of the gene expression program from a pro-inflammatory M1 signature to an M2-like anti-inflammatory phenotype [49] . Thus, we evaluated the phenotype transition from M1 to M2 to confirm whether it is related to the decreased production of IL-1β, IL-6 and TNF-α. In addition, iNOS is important surface markers of M1 macrophages [50] . As shown in Figure 1 , GLP-2 inhibited the gene and protein expression of iNOS in LPS-stimulated macrophages. Our result indicated that GLP-2 might promote a shift from the M1 to M2 macrophage phenotype by decreasing the expression of iNOS in LPS stimulated cells.
In summary, the results of this study provide evidence that GLP-2 might exhibits its anti-inflammatory effects via promoting a shift from the M1 to M2 macrophage phenotype and the suppression of NF-κB activity and ERK phosphorylation. These findings provide a new molecular insight into the mechanism by which GLP-2 exerts its anti-inflammatory function. Our results suggest that GLP-2 may be an attractive candidate as a therapeutically important anti-inflammatory agent.
